Rheumatology

Better access to info and dialogue with HCPs on sexual issues for rheumatology patients

Copenhagen, Denmark, Friday 12 June 2009: Patients with rheumatic diseases want more information and better communication with healthcare professionals on the sexual issues related to their conditions, according to the results of a new study presented today at EULAR 2009, the Annual Congress of th...

New Report Defines Challenges for New Entrants in Key Rheumatology Markets

MedPredict's Rheumatology Thought Leader Panel Creates a 'Fantasy Formulary' For 2015 SCOTTSDALE, Ariz., April 7 /PRNewswire/ -- MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategi...

UCB Becomes Pinnacle Donor to the American College of Rheumatology Research and Education Foundation's Research Campaign

SAN FRANCISCO, Oct. 27 /PRNewswire/ -- 6:00 am PST -- UCB announced today the company has joined the American College of Rheumatology Research and Education Foundation (REF) as a Pinnacle sponsor of the program: "Within Our Reach: Finding a Cure for Rheumatoid Arthritis." The announcement was ...

American College of Rheumatology presents recommendations for rheumatoid arthritis therapy

To manage the painful and incapacitating symptoms of rheumatoid arthritis (RA), a chronic, inflammatory joint disease, the majority of patients rely on disease-modifying antirheumatic drugs (DMARDs). In addition to trusted nonbiologic DMARDs, a number of biologic agents now promise to improve tre...

Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis

...e, a 110 mg dose and a 150 mg dose, each administered once daily. The primary endpoint will be the ACR20, which is defined by the American College of rheumatology (ACR) as a 20 percent improvement in symptoms associated with rheumatoid arthritis. Multiple secondary endpoints will also be evaluated, including AC...

PracticeMatch Releases Results of Recent 'State of the Industry' Survey of Physician Recruiters

...ecialties such as Family Practice and Internal Medicine remained steady, an increase was seen in Neurology (48.6%), Cardiology (28%), Urology (25.6%), rheumatology (17.5%), and other specialties. As the physician shortage continues, these need reports are expected to continue to rise. Physician recruiter...

Central DuPage Hospital Ranks 35th in Orthopaedics in U.S. News Media Group's 2009-10 America's Best Hospitals

...thalmology; orthopedics; psychiatry; rehabilitation; respiratory disorders; rheumatology and urology. "I have watched our orthopaedic services continue to e...the 16 specialties -- all but ophthalmology, psychiatry, rehabilitation and rheumatology -- are predominantly driven by hard data. There are four components: reputa...

Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29

...crease in units sold due to share declines as a result of increased competitive activity. ENBREL continues to maintain a leading position in both the rheumatology and dermatology segments. Worldwide sales of Sensipar((R)) (cinacalcet) increased 11 percent to $167 million in the second quarter of 2009 vers...

Detecting early signs of osteoarthritis

...tion in the joint lining may also play a role in its development. The team from The University of Nottingham's physiotherapy education and academic rheumatology departments aim to find out if people with knee pain and/or knee osteoarthritis also have inflammation in their knees. Patients will attend the Cli...

Healthy Advice Networks Announces the Launch of PracticeWire; Technology to Deliver Real-time Healthcare Content to Physicians

...0. The company delivers patient-education programs in primary care, cardiology, women's health, pediatric, gastroenterology, urology, dermatology, and rheumatology practices. About Healthy Advice Networks Healthy Advice Networks' mission is to help consumers and healthcare professionals...

Rheumatology in Medical Technology

Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference

MISSISSAUGA, ON, Oct. 27 /PRNewswire-FirstCall/ - Nuvo Research Inc. (TSX: NRI), a Canadian drug development company focused on the research and development of drug products delivered to and through the skin using its topical and transdermal drug delivery technologies, today announced that stu...

Trubion Pharmaceuticals Announces Presentation of Positive TRU-015 and SBI-087 Data at the 2008 Annual European Congress of Rheumatology Meeting

SEATTLE, June 16 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN ) today announced presentation of data at the 2008 Annual European Congress of Rheumatology meeting in Paris demonstrating that repeat administration with TRU-015, Trubion's lead candidate for the treatment ...

Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology

SEATTLE and PARIS, June 12 /PRNewswire-FirstCall/ -- Targeted Genetics Corporation (Nasdaq: TGEN ) announced today that positive results of a Phase 1/2 clinical study demonstrate that tgAAC94, its investigational agent designed to inhibit activity of tumor necrosis factor-alpha (TNF-alpha), a...

NicOx' Naproxcinod Phase 3 Results Presented at American College of Rheumatology

SOPHIA ANTIPOLIS, France, Nov. 12 /PRNewswire-FirstCall/ -- NicOx S.A. (Eurolist: COX) today announced that results from the first pivotal phase 3 trial for naproxcinod in patients with osteoarthritis of the knee (the 301 study) were presented on November 10, 2007 at the 71st annual meeting of...

Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference

BARCELONA, SPAIN and SEATTLE, WA -- (MARKET WIRE) -- June 14, 2007 -- Targeted Genetics Corporation (NASDAQ: TGEN) today is reporting data from the dose escalation arm of the ongoing Phase I/II clinical study of tgAAC94 in patients with inflammatory arthritis. Philip J. Mease, M.D., clinical profe...

Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology

PETACH TIKVA, Israel--(BUSINESS WIRE)--Jun 14, 2007 - Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange Exchange, proceeds with the development of its third drug CF502; this is in addition to CF101, which is currently in clinical trials and CF102, which i...

R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent

...ients continued to receive their stable dose of methotrexate. Efficacy assessments for each participant were based on the American College of rheumatology criteria, which denotes at least a 20% (ACR 20) improvement, at least a 50% (ACR 50) improvement, or at least a 70% (ACR 70) improvement, from the bas...

Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)

...Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology and gastroenterology treatments and seek to bring innovative products to patients through a pipeline that includes compounds in development for diabet...

Lupus Research Institute Highly Encouraged by Benlysta(TM) Trial Results

...e entire lupus community!" said Richard Furie, MD, chief of the division of rheumatology and allergy-clinical rheumatology at North Shore-LIJ Health System in New York. "There is no doubt that a dru...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

...d placebo treatment groups. No malignancies were reported. Professor Sandra V. Navarra, M.D., a principal investigator and Head of rheumatology at the University of Santo Tomas, Manila, The Philippines, said, "Given the limitations of available therapies, there is a great need for well tolerat...

Rheumatology in Medical Products

Thompson's Rheumatology Pocket Reference for PDA

Description: PDA-version of the standard reference work in rheumatology....
Company:USBMIS Inc.

Stedman's Medical Dictionary, 28th ed.

Features:...n 107,000 total terms Reviewed by consultants from medical and health science specialities including Endocrinology, Gastroenterology, Geriatrics, and rheumatology Access to thousands of medical terms, drug names, eponyms, procedures and protocols With Skyscape's smARTlink™ technology, Dorlands2™ can ...
Company:Skyscape, Inc.

Rheumatology in Medical Definition

Pathology

...ogy - Infectious disease - Intensive care medicine (Critical care medicine) - Medical genetics - Nephrology - Oncology - Pulmonology - rheumatology Surgical subspecialties Cardiac surgery - General surgery - Hand surgery - Neurosurgery - Oral and maxillofacial surgery - Ortho...

Medicine

...nsive care medicine Nephrology Oncology Pulmonology rheumatology Urology Neurology is concerned with the diagnosis and tre...icine) - Medical genetics - Nephrology - Oncology - Pulmonology - rheumatology Surgical subspecialties Cardiac surgery - General surgery - ...

Rheumatology in Medical Dictionary

Polymyositis

...es (those involved with making movement) on ... People with polymyositis may also experience arthritis, shortness of breath, ... ... Division of rheumatology provides state-of-the-art treatment for polymyositis and dermatomyositis. ... Polymyositis tends to be more severe and difficult to ... Visi...

Polyarteritis nodosa

...symptoms, diagnosis, misdiagnosis, treatment, causes, patient stories, videos, forums, prevention, and prognosis. At Cedars-Sinai, the Division of rheumatology provides state-of-the-art treatment for polyarteritis nodosa . ... Polyarteritis nodosa causes sections of the ... Polyarteritis nodos...

Nephritis

...can Academy of Family Physicians. ... Home > Conditions A-Z > Interstitial Nephritis . Advanced Search ... At Cedars-Sinai, the Division of rheumatology provides state-of-the-art treatment for lupus nephritis . ... Lupus nephritis is an inflammation of the kidney ... Both types of nephr...

Lupus nephritis

... systemic lupus erythematosus. ... Lupus nephritis affects approximately 50 percent of patients during ... At Cedars-Sinai, the Division of rheumatology provides state-of-the-art treatment for lupus nephritis . ... Lupus nephritis is an inflammation of the kidney ... Learn about kidne...

Lung surgery

...take from 2 to 6 hours. Video-assisted thorascopic surgery : ... Patient's Guide to Lung Surgery . Our Physicians. Contact Us. The Division of rheumatology ... Surgery removes part or all of a lung to eliminate the cancer. ... An overview of the various surgical approaches to lung surgery for ...

Henoch

... faction to Sargon's. ... In 2268, Henoch occupied Spock's body and decided that he would not give it up. ... At Cedars-Sinai, the Department of rheumatology provides state-of-the-art treatment for Henoch -Schönlein Purpura. ... purpura, Henoch -Schönlein purpura ... Henoch -Schonlein is a type o...

Rheumatology in Biological News

New trigger for chronic inflammation in rheumatoid arthritis discovered

... between tenascin-C and TLR4, which may help to combat rheumatoid arthritis. Dr Kim Midwood, lead author of the study from the Kennedy Institute of rheumatology at Imperial College London, said: "Rheumatoid arthritis is a debilitating and painful disease and, unfortunately, there is no cure. Furthermore, curre...

Enzyme involved in inflammatory bowel disease discovered at Penn State College of Medicine

...nd, Ph.D., Distinguished Professor and Chair of Biochemistry and Molecular Biology at Penn State College of Medicine, and Daniel Lottaz, Department of rheumatology and Clinical Immunology at the University of Bern, Switzerland, could potentially lead to therapies to help the half-a-million Americans affected by u...

Open access research celebrated

...f the Year Derek Rajakumar, University of Saskatchewan Mycobacterium tuberculosis monoarthritis in a child Rajakumar D, Rosenberg AM Pediatric rheumatology 2008, 6:15 (18 September 2008) http://www.ped-rheum.com/content/6/1/15 This case demonstrates the unusual ways that tuberculosis can present i...

To fight drug addiction, UB researchers target the brain with nanoparticles

.... Schwartz, M.D., Ph.D., professor in the UB departments of Medicine, Pediatrics and Microbiology, director of the Division of Allergy, Immunology and rheumatology in the UB School of Medicine and Biomedical Sciences, and a co-author on the study. The PNAS paper describes the development of an innovative way to...

A worm-and-mouse tale: B cells deserve more respect

...r treatments for many types of disease. In the past few years, Frances Lund, Ph.D., professor of Medicine in the Division of Allergy/Immunology and rheumatology at the University of Rochester Medical Center, has found an array of unexpected functions for B cells. In the laboratory, she has found that B cells p...

Adult stem cell breakthrough

...lieve this success has proved that we are on the verge of a new age in surgical care". Anthony Hollander, Arthritis Research Campaign Professor of rheumatology and Tissue Engineering at the University of Bristol, concurred: "This successful treatment manifestly demonstrates the potential of adult stem cells t...

Geisinger research: Antimalarial drug prevents diabetes in arthritis patients

...s diabetes onset but it's suspected that HCQ improves glucose tolerance. Dr. Bili presented the study's findings Monday at the American College of rheumatology Annual Scientific Meeting in San Francisco. About 23.6 million Americans have diabetes, while 1.3 million have rheumatoid arthritis. People wit...

New guidelines for treating rheumatoid arthritis

...d arthritis (RA), according to guidelines issued by the American College of rheumatology and co-authored by physicians at the University of Alabama at Birmingham (U...oward the most updated recommendations. The last set of American College of rheumatology RA treatment guidelines was published in 2002. "The recommendations deve...

DNA variations signal lupus risk

....D., a professor of medicine in the UAB Division of Clinical Immunology and rheumatology and co-author on the new study. The findings are published in the journa...ociate professor of medicine in the UAB Division of Clinical Immunology and rheumatology and co-author on the study. Using the data from the study, UAB researche...

Steps toward Stopping Autoimmune Disease

...ed to see the findings in print and are grateful that the ALR support for SLEGEN has had such a fruitful outcome, said Joseph E. Craft, M.D., chief of rheumatology at Yale University School of Medicine and former chair of the ALR Scientific Advisory Board. ...

Rheumatology in Biological Technology

Savient's Pegloticase Data in Treatment-Failure Gout Patients Presented at 72nd Annual Meeting of the American College of Rheumatology Conference

Phase 3 and Open Label Extension Results Support Efficacy and Safety of Pegloticase EAST BRUNSWICK, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today announced that data from its pegloticase pivotal clinical studies in treatment-failure gout (TFG) p...

ACTEMRA(R) (tocilizumab) Studies to be Featured at American College of Rheumatology Annual Scientific Meeting

- Phase III data highlight the benefits of ACTEMRA for rheumatoid arthritis - NUTLEY, N.J., Oct. 20 /PRNewswire/ -- Roche today announced that a total of 15 abstracts involving its investigational rheumatoid arthritis (RA) treatment ACTEMRA(R) (tocilizumab) have been accepted for presentatio...

Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting

SEATTLE, Oct. 1 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN ) today announced that two abstracts, including its late-breaking abstract for TRU-015 for rheumatoid arthritis (RA), have been accepted for presentation at the American College of Rheumatology (ACR) Annual S...

MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology

GAITHERSBURG, Md., Oct. 23 /PRNewswire/ -- MedImmune today announced that researchers will present eight posters from its inflammatory disease program at the Annual Meeting of the American College of Rheumatology, from October 24 to 29, 2008 at the Moscone Center in San Francisco, California. ...

Ardea Biosciences Presents Inflammation Program Data for Arthritis and Gout at 2008 Annual European Congress of Rheumatology

- RDEA119 Produced Significant Beneficial Effect in Animal Models of Arthritis - - RDEA594 Shows Promise as an Effective Treatment for Gout - SAN DIEGO, June 11 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ) today announced that data will...

Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)

...erall health for anyone, especially for individuals living with RA. The show also features: W. Hayes Wilson, M.D. , Chief, Division of rheumatology at Piedmont Hospital in Atlanta, Georgia, who discusses the importance of taking charge of your health and two-way communication with a doctor. ...

Healthy Advice Networks Announces Improved Patient Outcomes in Physicians' Offices with Healthy Advice Programs

...0. The company delivers patient-education programs in primary care, cardiology, women's health, pediatric, gastroenterology, urology, dermatology, and rheumatology practices. About Healthy Advice Networks Healthy Advice Networks' mission is to help consumers and healthcare professionals make more ...

Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus

...active SLE patients treated with belimumab through four years," said William W. Freimuth, M.D., Ph.D., Vice President, Clinical Research - Immunology, rheumatology and Infectious Diseases. "We are also encouraged by the safety data presented at EULAR. The incidence rates per 100 patient years of all adverse eve...

New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives

...opean League Against Rheumatism Annual Congress of rheumatology COPENHAGEN, Denmark, June 10 /PRNewswire-Firs...ague Against Rheumatism (EULAR) Annual Congress of rheumatology in Copenhagen. The RAISE survey sheds light o...urmester, MD, Professor of Medicine, Department of rheumatology and Clinical Immunology, Charite University Hospit...

Document Management Inefficiencies Cost Clinical Study Sites Time, Money

...th heaviest concentrations in cardiology (35.3 percent), internal medicine (26 percent), diabetes (24 percent), pulmonary/respiratory (21 percent) and rheumatology (20 percent). About IntraLinks IntraLinks provides on-demand solutions for businesses to securely collaborate, communicate and exchange criti...